Santa Fe, NM (PRWEB) November 25, 2014

Helios CORP, the maker of EstroG-100, has announced that they will be testing EstroG-100 in a side-by-side comparison with Black Cohosh. EstroG-100 has performed exceptionally in three clinical studies as a natural menopause ingredient. Among the results, studies showed that EstroG-100 works 6 times faster than Black Cohosh and has no estrogenic effect nor does it affect weight, body mass index, or liver enzymes. (1)

“Many women are still taking Black Cohosh as a daily treatment for menopause symptoms; however, a variety of published studies show Black Cohosh is linked to liver toxicity, among other health risks,” (2) said Michael Jeffers, the president of Helios CORP. “EstroG-100 is new to the U.S. market, so we’re still educating consumers that there’s actually an effective and safe botanical treatment for menopause symptoms. We feel the best way to demonstrate that there is a better and safer choice than Black Cohosh is to launch a side-by-side study with EstroG-100.”

The 45 million women in menopause in 2013 combined with the projected 5,000 women slipping into menopause per day in the USA will take something for menopause daily for 5-7 years and as long as 15 years. (3) It is critical that women have a safe and effective treatment for menopause symptoms.

A report by the North American Menopause Society from October 2012 suggests that Black Cohosh should not be used frequently due to potential liver toxicity issues (4), and in 2013 the American Botanical Council published a paper in which Black Cohosh was shown to be one the most adulterated botanical extracts sold in the USA. (5)

EstroG-100 has been shown to be one of the safest and most effective menopause symptom ingredients on the market, having achieved an “NDI” rating by the FDA, the highest classification in the dietary supplement industry. The ingredient has shown proven success treating hot flashes, vaginal dryness, sleeplessness, fatigue, dizziness, nervousness, and menopause related blues. (6)

Most botanical menopause remedies take 6-8 weeks to work and may affect just one of the many symptoms associated with menopause. After three placebo controlled, double blind and randomized human clinical studies, EstroG-100 has been proven to work with unheard of speed—in as little as a week—and improve multiple symptoms for menopausal women.

For additional information about EstroG-100, please contact Michael Jeffers at info(at)estroG100(dot)com, or visit us online for more information at http://www.estroG100.com.

Resources:

Helios CORP conducted three human clinical studies. Two of the three are currently published.

(1). Phase 2: “The Effect of Herbal Extract (EstroG-100) on Pre-, Peri- and Post-Menopausal Women,” Phytotherapy Research. 26: 510-516 (2012); Published online September 2, 2011 in Wiley Online Library. website: estrog100.com/media/files/04-EstroG-100-Phase-II_US-ClinicalStudy.pdf

(2). Mahady G, Low Dog T, Barrett M, Chavez M, Gardiner P, Ko R, et al. “United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity,” Menopause: The Journal of the North American Menopause Society. 2008;15(4 Pt 1):628–638. website: drlowdog.com/Assets/pdf_files/BlackCohoshReview_USP.pdf

(3). North American Menopause Society. Overview of menopause and aging.October 15, 2012, website: menopause.org/docs/2012/cg_a.pdf?sfvrsn=2

(4). Gass MD, Margery. “Supplement safety: black cohosh & menopausal symptoms,” The North American Menopause Society. Oct 31 2012. website: menopause.org/for-women/menopause-take-time-to-think-about-it/consumers/2012/10/31/supplement-safety-black-cohosh-menopausal-symptoms

(5). Foster, Steven. “Exploring the Peripatetic Maze of Black Cohosh Adulteration: A Review of the Nomenclature, Distribution, Chemistry, Market Status, Analytical Methods, and Safety,” American Botanical Council. Issue 98, 32-51. Website: cms.herbalgram.org/herbalgram/issue98/hg98feat-blackcohosh.html?ts=1416884557&signature=92db80f3f0f61d62f61899e7cf92c87d&ts=1416928696&signature=38ceace21274fe419e907e9af7582d90

(6). Phase 1: “Evaluation of Effectiveness and Safety of Natural Plants Extract (Estromon®) on Perimenopausal Women for 1 Year,” Journal of Korea Society of Menopause, Vol 11, No. 1, March 2005. Website: estrog100.com/media/files/05-EstroG-100-KoreaHumanClinicalStudy.pdf






Related Chemistry Press Releases

Tags